down arrow

Genpact Ltd.

  • Market Cap: Small Cap
  • Industry: Miscellaneous
  • ISIN: BMG3922B1072
USD
46.01
0.81 (1.79%)

Dec 04

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

45.4346.21

52 Week

37.5056.76
Valuation
Technical
Day's Volume

CASH

1.95 M

Shareholding (Mar 2025)

FII

24.73%

Held by 208 FIIs

DII

14.23%

Held by 75 DIIs

Promoter

7.22%

How big is Genpact Ltd.?

22-Jun-2025

As of Jun 18, Genpact Ltd. has a market capitalization of 7,593.78 million, with net sales of 4,848.03 million and a net profit of 527.57 million over the latest four quarters.

Market Cap: As of Jun 18, Genpact Ltd. has a market capitalization of 7,593.78 million, categorizing it as a Mid Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Genpact Ltd. reported net sales of 4,848.03 million and a net profit of 527.57 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 2,389.61 million and total assets of 4,987.15 million.

Read More

What does Genpact Ltd. do?

22-Jun-2025

Genpact Ltd. provides digitally powered business process management and services, classified as a mid-cap company with a market cap of approximately USD 7.59 billion. As of March 2025, it reported net sales of USD 1.21 billion and a net profit of USD 131 million.

Overview:<BR>Genpact Ltd. is engaged in providing digitally powered business process management and services, operating within the Miscellaneous industry and classified as a mid-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 1,214 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 131 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 7,593.78 Million (Mid Cap)<BR><BR>Key Metrics:<BR>P/E: 14.00 <BR>Dividend Yield: 154.01% <BR>Debt Equity: 0.29 <BR>Return on Equity: 21.71% <BR>Price to Book: 3.10 <BR><BR>Contact Details:<BR>Address: Canon's Court, 22 Victoria Street, HAMILTON None: HM 12 <BR>Tel: 1 441 2952244 <BR>Website: http://www.genpact.com/

Read More

Who are in the management team of Genpact Ltd.?

22-Jun-2025

As of March 2022, the management team of Genpact Ltd. includes Mr. James Madden (Independent Chairman), Mr. N. Tyagarajan (CEO), and several Independent Directors: Mr. Ajay Agrawal, Ms. Stacey Cartwright, Ms. Laura Conigliaro, and Ms. Carol Lindstrom. They oversee the company's strategic direction and operations.

As of March 2022, the management team of Genpact Ltd. includes the following individuals:<BR><BR>- Mr. James Madden, who serves as the Independent Chairman of the Board.<BR>- Mr. N. Tyagarajan, who is the President, Chief Executive Officer, and a Director.<BR>- Mr. Brian Stevens, who is a Director.<BR>- Mr. Ajay Agrawal, who is an Independent Director.<BR>- Ms. Stacey Cartwright, who is an Independent Director.<BR>- Ms. Laura Conigliaro, who is an Independent Director.<BR>- Ms. Carol Lindstrom, who is an Independent Director. <BR><BR>This team is responsible for guiding the company's strategic direction and operations.

Read More

Is Genpact Ltd. technically bullish or bearish?

07-Oct-2025

As of October 3, 2025, Genpact Ltd. is in a bearish trend, indicated by bearish momentum from the MACD and moving averages, despite a mildly bullish KST signal, and has underperformed the S&P 500 with a year-to-date return of -4.28%.

As of 3 October 2025, the technical trend for Genpact Ltd. has changed from mildly bearish to bearish. The current technical stance is bearish, with key indicators such as the MACD on a weekly basis indicating bearish momentum, and moving averages also reflecting a bearish outlook. Bollinger Bands confirm a bearish trend in both weekly and monthly time frames. The KST shows a mildly bullish signal on the weekly but is bullish on the monthly, which contrasts with the overall bearish sentiment. Additionally, the stock has underperformed against the S&P 500 across multiple periods, with a 1-week return of -2.51% compared to the S&P 500's 1.09%, and a year-to-date return of -4.28% against the S&P 500's 14.18%.

Read More

Is Genpact Ltd. overvalued or undervalued?

21-Oct-2025

As of October 17, 2025, Genpact Ltd. is fairly valued with a P/E ratio of 14 and has underperformed the S&P 500 over the last three years, returning -12.78% compared to the index's 81.19%.

As of 17 October 2025, the valuation grade for Genpact Ltd. has moved from attractive to fair, indicating a shift in its perceived value. The company appears to be fairly valued based on its current metrics, with a P/E ratio of 14, an EV to EBITDA of 10.29, and a Price to Book Value of 3.09. In comparison to peers, ICON plc has a P/E of 14.64, while Booz Allen Hamilton Holding Corp. has a P/E of 15.81, suggesting that Genpact is positioned competitively within its industry.<BR><BR>Despite its fair valuation, Genpact has underperformed against the S&P 500 in various timeframes, particularly over the last three years, where it returned -12.78% compared to the S&P 500's 81.19%. This underperformance may indicate that while the stock is fairly valued, it may not be the best investment opportunity relative to broader market performance.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

High Management Efficiency with a high ROCE of 19.50%

 
2

Company has a low Debt to Equity ratio (avg) at times

 
3

Healthy long term growth as Operating profit has grown by an annual rate 10.73%

 
4

Positive results in Jun 25

5

With ROCE of 22.82%, it has a fair valuation with a 2.62 Enterprise value to Capital Employed

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Miscellaneous

stock-summary
Market cap

USD 7,759 Million (Small Cap)

stock-summary
P/E

14.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

150.73%

stock-summary
Debt Equity

0.27

stock-summary
Return on Equity

20.86%

stock-summary
Price to Book

3.00

Revenue and Profits:
Net Sales:
1,255 Million
(Quarterly Results - Jun 2025)
Net Profit:
133 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
2.31%
0%
2.31%
6 Months
7.95%
0%
7.95%
1 Year
1.14%
0%
1.14%
2 Years
32.48%
0%
32.48%
3 Years
0.13%
0%
0.13%
4 Years
-6.39%
0%
-6.39%
5 Years
12.22%
0%
12.22%

Genpact Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Genpact Ltd. Hits Day High with 15.89% Surge in Stock Price

Genpact Ltd. Hits Day High with 15.89% Surge in Stock Price

Genpact Ltd. saw a notable rise in its stock price on November 7, 2025, reaching an intraday high. The company has demonstrated strong short-term performance, although it has underperformed compared to the S&P 500 over the past year. Genpact maintains solid financial metrics, including high management efficiency and low debt levels.

Read More
Genpact Stock Plummets to New 52-Week Low at $37.50

Genpact Stock Plummets to New 52-Week Low at $37.50

Genpact has hit a new 52-week low of USD 37.50, reflecting a notable decline in its performance compared to the S&P 500. The company, with a market cap of USD 7,759 million, shows a low debt-to-equity ratio and high management efficiency, but its net profit has decreased significantly.

Read More
Genpact Stock Plummets to 52-Week Low at USD 37.77

Genpact Stock Plummets to 52-Week Low at USD 37.77

Genpact has reached a new 52-week low, trading at USD 37.77, reflecting a notable decline for the small-cap company. Despite a low debt-to-equity ratio and strong management efficiency, its net profit has decreased significantly. The stock is trading at a discount compared to historical valuations.

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
6.21%
EBIT Growth (5y)
10.73%
EBIT to Interest (avg)
9.29
Debt to EBITDA (avg)
1.38
Net Debt to Equity (avg)
0.29
Sales to Capital Employed (avg)
1.25
Tax Ratio
24.16%
Dividend Payout Ratio
21.43%
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
19.50%
ROE (avg)
21.97%
Valuation key factors
Factor
Value
P/E Ratio
14
Industry P/E
Price to Book Value
3.09
EV to EBIT
11.48
EV to EBITDA
10.29
EV to Capital Employed
2.62
EV to Sales
1.71
PEG Ratio
NA
Dividend Yield
150.00%
ROCE (Latest)
22.82%
ROE (Latest)
21.71%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 124 Schemes (53.8%)

Foreign Institutions

Held by 208 Foreign Institutions (24.73%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 3.35% vs -2.72% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 1.38% vs -7.75% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,254.60",
          "val2": "1,213.90",
          "chgp": "3.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "199.00",
          "val2": "207.60",
          "chgp": "-4.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "17.90",
          "val2": "17.60",
          "chgp": "1.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.80",
          "val2": "4.60",
          "chgp": "-17.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "132.70",
          "val2": "130.90",
          "chgp": "1.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "143.40%",
          "val2": "155.50%",
          "chgp": "-1.21%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 6.46% vs 2.47% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -18.63% vs 78.64% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,764.90",
          "val2": "4,475.60",
          "chgp": "6.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "772.40",
          "val2": "713.50",
          "chgp": "8.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "80.90",
          "val2": "74.60",
          "chgp": "8.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-10.30",
          "val2": "18.50",
          "chgp": "-155.68%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "513.70",
          "val2": "631.30",
          "chgp": "-18.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "144.10%",
          "val2": "138.70%",
          "chgp": "0.54%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
1,254.60
1,213.90
3.35%
Operating Profit (PBDIT) excl Other Income
199.00
207.60
-4.14%
Interest
17.90
17.60
1.70%
Exceptional Items
3.80
4.60
-17.39%
Consolidate Net Profit
132.70
130.90
1.38%
Operating Profit Margin (Excl OI)
143.40%
155.50%
-1.21%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 3.35% vs -2.72% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 1.38% vs -7.75% in Mar 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
4,764.90
4,475.60
6.46%
Operating Profit (PBDIT) excl Other Income
772.40
713.50
8.26%
Interest
80.90
74.60
8.45%
Exceptional Items
-10.30
18.50
-155.68%
Consolidate Net Profit
513.70
631.30
-18.63%
Operating Profit Margin (Excl OI)
144.10%
138.70%
0.54%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 6.46% vs 2.47% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -18.63% vs 78.64% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Genpact Ltd. stock-summary
stock-summary
Genpact Ltd.
Miscellaneous
Genpact Limited is engaged in providing digitally powered business process management and services. The Company's segments include Business process outsourcing and Information technology services. The Company offers various vertical activities, which include banking and financial services; capital markets; insurance; consumer goods and retail; life sciences and healthcare; infrastructure, manufacturing and services, and High Tech. In addition to these vertical activities, it also offers analytics and research, collections and customer services, consulting and transformation services, core industry operations services, enterprise application services, finance and accounting (F&A) services, information technology (IT) infrastructure management services, and supply chain and procurement services. The Company also offers data engineering and data-led digital transformation services.
Company Coordinates stock-summary
Company Details
Canon's Court, 22 Victoria Street , HAMILTON None : HM 12
stock-summary
Tel: 1 441 2952244
stock-summary
http://www.genpact.com/
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."